Diagnosis

Golomb, H.M., Catovsky, D., Golde, D.W.

(1978) Hairy cell leukemia: a clinical review based on 71 cases.
Ann Intern Med Nov;89(5 Pt 1):677-83.

Burke, J.S., Rappaport, H.

(1984) The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen.
Semin Oncol Dec;11(4):334-46.

Matutes, E., Morilla, R., Owusu-Ankomah, K., Houliham, A., Meeus, P., Catovsky, D.

(1994) The immunophenotype of hairy cell leukemia (HCL): proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Leukemia and Lymphoma, 14, (Suppl. 1), 57-62

Indications for treatment

Catovsky, D., Golomb, H.M., Golde, D.W.

(1987) General commentary on the Second International Workshop.
Leukemia, 1, 407-408

Fludarabine therapy

Kantarjian, H.M., Schachner, J., Keating, M.J.

(1991) Fludarabine therapy in hairy cell leukemia.
Cancer, 67, 1291-1293

Pentostatin

Kraut, E.H., Bouroncle, B.A., Grever, M.R.

(1989) Pentostatin in the treatment of advanced hairy cell leukemia.
Journal of Clinical Oncology, 7, 168-172

Catovsky, D., Matutes, E., Talavera, J.G., O'Connor, N.T.J., Johnson, S.A.N., Emmett, E., Corbett, L., Swansbury, J.

(1994) Long-term results with 2'-deoxycoformycin in hairy cell leukemia.
Leukemia and Lymphoma, 14, (Suppl.), 109-113

Urba, W.J., Baseler, M.W., Kopp, W.C., Steis, R.G., Clark, J.W., Smith, J.W., Coggin, D.L., Longo, D.L.

(1989) Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
Blood, 73, 38-46

Kraut, E.H., Grever, M.R., Bouroncle, B.A.

(1994) Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycin.
Blood, 84, 4061-4063

Cladribine

Piro, L.D., Carrera, C.J., Carson, D.A., Beutler, E.

(1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
New England Journal of Medicine, 322:1117-1121

Lauria, F., Bocchia, M., Marotta, G., Raspadori, D., Zinzani, P.L., Rondelli, D.

(1997) Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Blood, 89, 1838-1839

Saven, A., Burian, C., Koziol, J.A., Piro, L.D.

(1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
Blood, 92, 1918-1926

IFN & splenectomy

Smalley, R.V., Connors, J., Tuttle, R.L., Anderson, S., Robinson, W., Whisnant, J.K.

(1992) Splenectomy vs alpha interferon: a randomised study in patients with previously untreated hairy cell leukemia.
American Journal of Hematology, 41, 13-18

Monoclonal therapies

Thomas, D.A., O'Brien, S., Bueso-Ramos, C., Faderl, S., Keating, M.J., Giles, F.J., Cortes, J., Kantarjian, H.M.

(2003) Rituximab in relapsed or refractory hairy cell leukemia.
Blood. Dec 1;102(12):3906-11

Kreitman, R.J., Wilson, W.H., Bergeron, K., Raggio, M., Stetler-Stevenson, M., FitzGerald, D.J., Pastan, I.

(2001) Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.
N Engl J Med 345:241–247

Return to Table of Contents